Results 121 to 130 of about 12,362 (197)

Antifungal susceptibility, molecular epidemiology, and clinical risk factors of Candida glabrata in intensive care unit in a Chinese Tertiary Hospital

Frontiers in Cellular and Infection Microbiology
BackgroundThe increasing incidence and high mortality rate of Candida glabrata infection in ICU patients is an important issue. Therefore, it is imperative to investigate the antifungal susceptibility profiles and epidemiological characteristics in local
Si-Jia Huang, Si-Jia Huang, Geng Lv, Geng Lv, Yi-Hui Song, Jun-Tao Zhao, Jin-Yan Liu, Lu-Ling Wang, Lu-Ling Wang, Ming-Jie Xiang, Ming-Jie Xiang   +10 more
doaj   +1 more source

Estado actual de las resistencias de Candida a los fármacos antifúngidos y estudio de los mecanismos implicados [PDF]

, 2018
[ES] El género Candida se encuentra taxonómicamente ubicado dentro del reino Fungi,subreino Dikarya y orden Sacharomycetales (Bonifaz, 2012). Se trata de una levadura redonda u ovalada de 4-6 μm de tamaño denominada blastoconidio, que forma gemaciones ...
Bilbao Bilbao, Nagore
core  

The Surgical Infection Society revised guidelines on the management of intra-abdominal infection [PDF]

, 2017
Background: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update
Chang, Phillip K, Diaz, Jose J, Jr, Huston, Jared M, May, Addison K, Mazuski, John E, Mollen, Kevin P, Nadler, Evan P, O\u27Neill, Patrick J, Prince, Jose M, Rosengart, Matthew R, Sawyer, Robert G, Tessier, Jeffrey M   +11 more
core   +3 more sources

Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms

Infection and Drug Resistance, 2018
Meng Xiao,1,2,* Xin Fan,1–3,* Xin Hou,1,2,4,* Sharon CA Chen,5 He Wang,1,2 Fanrong Kong,5 Zi-Yong Sun,6,* Yun-Zhuo Chu,7 Ying-Chun Xu1,2 1Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences,
Xiao M, Fan X, Hou X, Chen SCA, Wang H, Kong F, Sun ZY, Chu YZ, Xu YC   +8 more
doaj  

Tolerance and heteroresistance to echinocandins in Candida auris: conceptual issues, clinical implications, and outstanding questions

mSphere
Candida auris is a significant public health threat due to its environmental persistence and multidrug resistance, with echinocandins being the preferred treatment.
Erika Shor, David S. Perlin, Dimitrios P. Kontoyiannis   +2 more
doaj   +1 more source

Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance

mSphere, 2018
Candida species are a major cause of life-threatening bloodstream infections worldwide. Although Candida albicans is responsible for the vast majority of infections, the clinical relevance of other Candida species has also emerged over the last twenty ...
Csaba Papp, Katica Kocsis, Renáta Tóth, László Bodai, Jesse R. Willis, Ewa Ksiezopolska, Nancy E. Lozoya-Pérez, Csaba Vágvölgyi, Hector Mora Montes, Toni Gabaldón, Joshua D. Nosanchuk, Attila Gácser   +11 more
doaj   +1 more source

Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition [PDF]

, 2018
Candidiases are the most recurrent fungal infections, especially among immunosuppressed patients. Although Candida albicans is still the most widespread isolated species, non-Candida albicans Candida species have been increasing.
Arendrup MC, Célia F. Rodrigues, De Luca C, Grandesso S, Jabra-rizk MA, Maria Elisa Rodrigues, Mariana Henriques, Pappas PG, Pfaller MA, Williams DW   +9 more
core   +1 more source

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches

Infection and Drug Resistance, 2021
Anna Maria Tortorano,1 Anna Prigitano,1 Gianluca Morroni,2 Lucia Brescini,2,3 Francesco Barchiesi2,4 1Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy; 2Department of Biomedical Sciences and Public Health ...
Tortorano AM, Prigitano A, Morroni G, Brescini L, Barchiesi F   +4 more
doaj  

Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates. [PDF]

, 2017
<i>Candida glabrata</i> is an important fungal pathogen which develops rapid antifungal resistance in treated patients. It is known that azole treatments lead to antifungal resistance in this fungal species and that multidrug efflux ...
Beaudoing, E., Sanglard, D., Tran, VDT, Vale-Silva, L.   +3 more
core   +2 more sources

Tipping the balance both ways: drug resistance and virulence in Candida glabrata [PDF]

, 2017
Among existing fungal pathogens, Candida glabrata is outstanding in its capacity to rapidly develop resistance to currently used antifungal agents. Resistance to the class of azoles, which are still widely used agents, varies in proportion (from 5 to 20%)
Bolotin-Fukuhara, Monique, Sanglard, Dominique, Vale-Silva, Luis A.   +2 more
core